Goettingen, Germany | Aubagne, France, June 28, 2012 / B3C newswire / - Sartorius Stedim Biotech, a leading international supplier for the pharma and biotech industries, has launched the BioWelder® Total Containment (TC). BioWelder® TC featuring innovative technology permits sterile connection of liquid-filled thermoplastic tubing that has an outer diameter (OD) of up to 1 inch and that is used on disposable bags or bag assemblies in all biopharmaceutical manufacturing processes. The sterile welding process is fully automated and can be performed in non- classified or classified environments while maintaining product sterility.
The thermal weld produced by BioWelder® TC ensures an extraordinary level of stability, thus guaranteeing an ultra-safe connection. The thermal weld has been qualified by applying the most stringent and innovative test regimes. Biological, physical and extractables tests were combined to obtain data representing a variety of process conditions, including critical applications.
A profile of Sartorius Stedim Biotech
Sartorius Stedim Biotech is a leading provider of cutting-edge equipment and services for the development, quality assurance and production processes of the biopharmaceutical industry. Its integrated solutions covering fermentation, cell cultivation, filtration, purification, fluid management and lab technologies are supporting the biopharmaceutical industry around the world to develop and produce drugs safely, timely and economically. Sartorius Stedim Biotech focuses on single-use technologies and value-added services to meet the rapidly changing technology requirements of the industry it serves. Strongly rooted in the scientific community and closely allied with customers and technology partners, the company is dedicated to its philosophy of “turning science into solutions.”
Headquartered in Aubagne, France, Sartorius Stedim Biotech is listed on the Eurolist of Euronext Paris. With its own manufacturing and R&D sites in Europe, North America and Asia and a global network of sales companies, Sartorius Stedim Biotech enjoys a worldwide presence. Its key manufacturing and R&D site is in Germany. The company employs approx. 2,850 people, and in 2011 earned sales revenue of 477.3 million euros.
Press contact:
Dominic Grone
Sartorius Group Corporate Communications
Sartorius Corporate Administration GmbH
D-37070 Goettingen
Germany
Phone: +49(0)551/ 308-3324
Fax: +49(0)551/ 308-3572
E-mail: dominic.grone@sartorius.com
www.sartorius.com
